Publications by authors named "Calvin N Ho"

Claim this Profile
T
The role of patient-reported outcomes in health technology assessments: global practices and future implications.
Nenad Medic, James Ryan, Calvin N Ho, Livia Lai, Olivier Chassany

Expert Rev Pharmacoecon Outcomes Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis.
Peter A Merkel, Parameswaran K Nair, Nader Khalidi, Benjamin Terrier, Bernhard Hellmich, Calvin N Ho

Ann Rheum Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Experiences of Bullous Pemphigoid: Symptoms and Health-Related Quality of Life Impacts.
Calvin N Ho, Lila Bahadori, Marc Yale, Naomi Bishop, Caroline Roberts

Dermatol Ther (Heidelb)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benralizumab for the treatment of chronic spontaneous urticaria: a plain language summary of the ARROYO study.
Sabine Altrichter, Ana Maria Giménez-Arnau, Jonathan A Bernstein, Martin Metz, Maria Bergquist, Calvin N Ho

Immunotherapy· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient experience with eosinophilic esophagitis symptoms and impacts on daily life based on in-trial qualitative interviews.
Calvin N Ho, Harald Fjällbrant, Evan S Dellon, Cecilio Santander, Marc E Rothenberg

J Patient Rep Outcomes· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing usability of electronic patient-reported outcome measures in older people with and without a rare dermatologic disorder.
Calvin N Ho, Anna Kündig, Lila Bahadori, Katy Roat, Rachel Bruce, Thomas Moll

J Patient Rep Outcomes· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating moderate-to-severe atopic dermatitis with benralizumab: results from the HILLIER study, a plain language summary.
Emma Guttman-Yassky, Lila Bahadori, Laura Brooks, Ken L Clark, Hanna Grindebacke, Calvin N Ho

Immunotherapy· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial.
Sabine Altrichter, Ana Maria Giménez-Arnau, Jonathan A Bernstein, Martin Metz, Lila Bahadori, Calvin N Ho

Br J Dermatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis.
Marc E Rothenberg, Evan S Dellon, Margaret H Collins, Albert J Bredenoord, Ikuo Hirano, Calvin N Ho

N Engl J Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and content validation of a symptom assessment for eosinophilic gastritis and eosinophilic gastroenteritis in adults and adolescents.
Calvin N Ho, Sean O'Quinn, Julie Bailey, Oren Meyers, Ashley F Slagle

Orphanet J Rare Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis